Table 2 Laboratory findings at follow-up time of the study population

WBC count, × 10⁹/L

6.6 (5.5–7.4)

6.7 (5.7–7.5)

6.5 (5.0–7.1)

6.0 (5.4–7.1)

0.382

0.656

RBC, × 10⁹/L

5.2 (4.7–5.4)

5.1 (4.7–5.4)

5.3 (4.8–5.5)

5.2 (4.8–5.5)

0.599

0.262

Ferritin, ng/ml,

91.0 (34.0–148.5)

59.0 (14.0–104.0)

136.0 (93.0–219.0)

47.0 (18.7–190.0)

0.460

0.002

Platelet count, × 10³/Ml

224 (195–260)

226 (200–269)

221 (186–247)

201 (189–245)

0.226

0.433

Hematocrit, %

43.8 (39.4–45.8)

43.9 (38.6–45.9)

43.7 (40.7–45.1)

44.8 (41.9–47.4)

0.162

0.791

Hb, g/dL

15.0 (13.3–15.8)

14.9 (13.3–15.7)

15.1 (13.8–15.8)

15.7 (14.2–16.7)

0.059

0.641

AST, U/L

26.0 (20.8–32.0)

26.0 (20.0–32.0)

27.0 (22.0–34.0)

35.0 (30.5–39.0)

0.009

0.491

ALT, U/L

28.0 (18.0–41.8)

28.0 (18.0–40.0)

29.0 (18–50)

31.0 (24.3–42.3)

0.580

0.816

ALP

163.5(138–202)

163 (136–199)

180 (150–207)

161 (140–171)

0.605

0.849

Albumin, g/L

4.5 (3.9–4.7)

4.5 (4.0–4.8)

4.0 (3.8–4.6)

4.9 (4.7–5.1)

0.004

0.052

Total bilirubin, mmol/L

0.5 (0.4–0.8)

0.5 (0.4–0.7)

0.7 (0.4–1.2)

0.3 (0.3–0.6)

0.078

0.035

Direct bilirubin, mmol/L

0.19 (0.1–0.2)

0.2 (0.1–0.2)

0.2 (0.20.2)

0.2 (0.2–0.4)

0.018

0.705

Uric acid, mg/dl

4.4 (3.3–5.2)

4.1 (2.9–5.2)

4.4 (4.0–5.9)

3.9 ( 3.2–5.2)

0.910

0.127

BUN, mmol/L

26.0 (20.0–31.0)

25.0 (20.0–31.0)

28.0 (20.0–36.0)

23.0 ( 21.0–29.0)

0.319

0.539

Creatinine, mg/dl

1.0 (0.9–1.1)

1.0 (0.9–1.1)

1.1 (0.9–1.2)

1.1 (0.9–1.3)

0.386

0.780

FBS, mmol/L

94.5 (86.8–100.0)

96.0 (87.0–100.0)

91.0 (86.0–101.0)

81.0 (75.3–99)

0.015

0.890

HbA1C, %

5.05 (4.7–5.43)

5.0 (4.8–5.4)

5.2 (4.6–5.5)

4.6 (4.2–5.0)

0.004

0.983

TG, mmol/L

103 (82–158)

102 (80–153)

148 (83–192)

131 (83–168)

0.768

0.421

HDL, mg/dL

44.5 (39.7–54.0)

44 (39–58)

48 (42–50)

62 (51–67)

0.004

0.807

LDL, mg/dL

112 (97–137)

110 (96–127)

114 (99–140)

140 (114–157)

0.012

0.465

Cholesterol

173.5 (153.8–– 200.3)

168 (146–200)

175 (157–211)

177 (157–192)

0.760

0.357

PT ratio

1.0 (1.0–1.04)

1.0 (1.0–1.04)

1.0 (1.0–1.0)

1.04 (1.00–1.08)

0.086

0.379

INR

1.0 (1.0–1.05)

1.0 (1.0–1.05)

1.0 (1.0–1.0)

1.05 (1.00–1.10)

0.090

0.401

PTT

30.0 (29.0–31.0)

31.0 (29.0–31.0)

30.0 (29.0–32.0)

30.0 (29.5–31.8)

1.00

0.817

ESR 1st, mm/h

5.0 (2.0–14.0)

5.0 (3.0–14.0)

4.0 (2.0–16.0)

5.0 (2.0–9.0)

0.692

0.693

LDH, U/L

301 (259–353)

282 (256–341)

348 (299–391)

278 (264–315)

0.285

0.015

CPK-MB, U/L

18.5 (14.0–24.0)

18.0 (13.0–24.0)

20.0 (17.0–24.0)

15.0 (14.7–16)

0.073

0.156

Q-CRP, mg/L, 10 ≤ 

2.0 (1.37–2.3)

1.5 (1.2–2.1)

2.0 (1.4–3.0)

1.9 (1.5–2.7)

0.650

0.369

Troponin I, ng/ml < 0.04

0.12 (0.10–0.20)

0.14 (0.11–0.18)

0.1 (0.05–0.2)

0.12 (0.12–0.16)

0.789

0.293

TSHn, mIU/L

1.65 (0.78–2.43)

1.7 (0.7–2.4)

1.3 (0.8–3.6)

2.05 (1.8–3.2)

0.041

0.751

D3, ng/ml

19.5 (15.0–25.0)

18.0 (12.0–23.0)

23.0 (20.0–33.0)

21.5 (14.3–30.8)

0.544

0.015

Mg, mg/dL

2.4 (2.1–2.5)

2.4 (2.1–2.5)

2.2 (2.0–2.6)

2.1 (1.95–2.20)

0.016

0.481

SARS-Cov2-IgM, U/mL

0.4 (0.3–0.5)

0.4 (0.3–0.5)

0.4 (0.3–0.5)

–

–

0.757

SARS-Cov2-IgG, U/mL

2.2 (1.35–8.7)

1.7 (1.2–3.3)

7.8 (2.2–10.5)

–

–

0.017